" class="no-js "lang="en-US"> Sachin (Sach) Jain - Medtech Alert
Monday, October 13, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Sach Jain

Sachin (Sach) Jain

About Sachin (Sach) Jain

Related Story

Appointments

 Carrum Health Appoints Randy K. Hawkins

Carrum Health Appoints Randy K. Hawkins, M.D. as Chief Medical Officer

November 10 2021

Carrum Health, the first value-based Centers of Excellence (COEs) platform for surgical care, today announced Randy […]

Appointments

 Carrum Health Taps Pallav Sharda as Chief Platform Officer to Scale Technology Platform | Pharmtech Focus

Carrum Health Taps Pallav Sharda as Chief Platform Officer to Scale Technology Platform

August 12 2021

Carrum Health, the first digital health company connecting employers and employees to Centers of Excellence […]